Suppr超能文献

一种用于木瓜蛋白酶皮肤递送的新型弹性脂质体及其在增生性瘢痕上的应用。

A novel elastic liposome for skin delivery of papain and its application on hypertrophic scar.

作者信息

Chen Yan-Yan, Lu Ye-Hui, Ma Chun-Hua, Tao Wei-Wei, Zhu Jing-Juan, Zhang Xu

机构信息

College of Basic Medical, Nanjing University of Chinese Medicine, Nanjing 210023, China; Yunnan Baiyao Group Wuxi Pharmaceutical Co., Ltd., Wuxi 214028, China.

Yunnan Baiyao Group Wuxi Pharmaceutical Co., Ltd., Wuxi 214028, China; Yunnan Institute of Materia Medica, Yunnan 650111, China.

出版信息

Biomed Pharmacother. 2017 Mar;87:82-91. doi: 10.1016/j.biopha.2016.12.076. Epub 2016 Dec 29.

Abstract

This study aims to investigate the therapeutic effects of papain elastic liposomes (PEL) on hypertrophic scar through topical application. PEL were prepared using the reverse-phase evaporation method and optimized by response surface methodology. The transdermal absorption of optimized PEL was tested by vertical Franz diffusion cells in vitro. The effects of PEL were investigated in rabbit model of hypertrophic scar in vivo, histological analysis and scar-related proteins were detected to reveal potential scar repair mechanism. The best formulation of PEL had EE (43.8±1.4%), particle size (100.9±2.2nm), PDI (0.037±0.003), zeta potential (-26.3±1.3mV), and DI (21.9±3.1). PEL gave the cumulative amounts and steady state fluxes in the receiver solution of 381.9±32.4μg/cm, 11.4±1.5μg/cm/h, and showed drug deposition in skin of 19.1±3.2% after 24h. After topical application, the scar elevation index, microvascular density, and collagen fiber were significantly decreased with regular arrangement. The expressions of TGF-β, P-Smad-3, P-NF-κB p65, and P-IKBa in hypertrophic scar were significantly down regulated in contrast with those in model group. PEL were proven as an excellent topical preparation for hypertrophic scar treatment.

摘要

本研究旨在通过局部应用研究木瓜蛋白酶弹性脂质体(PEL)对增生性瘢痕的治疗效果。采用反相蒸发法制备PEL,并通过响应面法进行优化。采用垂直Franz扩散池体外测试优化后PEL的透皮吸收。在增生性瘢痕兔模型体内研究PEL的作用,检测组织学分析和瘢痕相关蛋白以揭示潜在的瘢痕修复机制。PEL的最佳配方具有包封率(43.8±1.4%)、粒径(100.9±2.2nm)、多分散指数(PDI,0.037±0.003)、ζ电位(-26.3±1.3mV)和药物分布系数(DI,21.9±3.1)。PEL在接收液中的累积量和稳态通量分别为381.9±32.4μg/cm、11.4±1.5μg/cm/h,24小时后皮肤中的药物沉积率为19.1±3.2%。局部应用后,瘢痕增生指数、微血管密度和胶原纤维明显降低且排列规则。与模型组相比,增生性瘢痕中转化生长因子-β(TGF-β)、磷酸化Smad-3(P-Smad-3)、磷酸化核因子-κB p65(P-NF-κB p65)和磷酸化IκBα(P-IκBα)的表达明显下调。PEL被证明是一种治疗增生性瘢痕的优秀局部制剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验